Akers Biosciences, Inc. Modification Agreements

10 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Omnibus Amendment Agreement between TNF Pharmaceuticals, Inc. and Investor (April 8, 2025)
Modification Agreements
Akers Biosciences, Inc.
Pharmaceuticals
NY
2025
Amendment to Warrant under Securities Purchase Agreement between TNF Pharmaceuticals, Inc. and Investor
Modification Agreements
Akers Biosciences, Inc.
Pharmaceuticals
2024
Amendment to Warrant Agreement between TNF Pharmaceuticals, Inc. and Investor (August 2024)
Modification Agreements
Akers Biosciences, Inc.
Pharmaceuticals
2024
Amendment to Warrant Terms under Securities Purchase Agreement between TNF Pharmaceuticals, Inc. and Investor
Modification Agreements
Akers Biosciences, Inc.
Pharmaceuticals
2024
Amendment to Warrant Terms under Securities Purchase Agreement between TNF Pharmaceuticals, Inc. and Investor
Modification Agreements
Akers Biosciences, Inc.
Pharmaceuticals
2024
Amendment Agreement to Certificate of Designations between TNF Pharmaceuticals, Inc. and Investor
Modification Agreements
Akers Biosciences, Inc.
Pharmaceuticals
2024
Amendment Agreement to Certificate of Designations between MyMD Pharmaceuticals, Inc. and Investor (June 17, 2024)
Modification Agreements
Akers Biosciences, Inc.
Pharmaceuticals
2024
Amendment to Warrants under Securities Purchase Agreement between MyMD Pharmaceuticals, Inc. and Investors
Modification Agreements
Akers Biosciences, Inc.
Pharmaceuticals
2024
First Amendment to Executive Chairman Agreement between MyMD Pharmaceuticals, Inc. and Christopher C. Schreiber
Modification Agreements
Akers Biosciences, Inc.
Pharmaceuticals
NJ
2023
First Amendment to Akers Biosciences, Inc. 2018 Equity Incentive Plan
Modification Agreements
Akers Biosciences, Inc.
Pharmaceuticals
2020